Open Access Critical Evidence Review

Mechanisms of stress, energy homeostasis, and insulin resistance in European adolescents - the HELENA study - Evidence review

In the 723 European adolescents of the HELENA study, higher cortisol concentrations were associated with higher insulin, glucose, or HOMA-IR index, with differences between sexes. The data suggest lower insulin sensitivity, but do not measure the receptor or IRS. Independent studies support some steps, especially experimental ones, and require further clinical caution.

Cite this article
Conte, A. (2026). Mechanisms of stress, energy homeostasis, and insulin resistance in European adolescents - the HELENA study - Evidence review. Life Science Hub Journal. DOI: 10.5281/zenodo.24304952. https://lifesciencehub.info/en/mechanisms-of-stress-energy-homeostasis-and-insulin-resistance-in-european-adolescents-the-helena
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24304952

Article history
Dates
  • Published 16/11/2026
  • Updated 17/11/2026
Revisions
  1. v1.0 — 16/11/2026 Initial publication of the article.
  2. v1.1 — 17/11/2026 Editorial update of content, sources or references.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Scientific still life with test tubes and biomarkers, representing cortisol, glycemia, and insulin resistance in European adolescents.
Biomarkers of stress and energy balance in a scientific context: cortisol is linked to lower insulin sensitivity in adolescents, with differences between the sexes.

ABSTRACT

The HELENA study examined, in 723 adolescents from ten European cities, the relationship between fasting cortisol, certain indicators of energy balance, and the HOMA-IR index, an indirect estimate of insulin resistance calculated from fasting glycemia and insulin. In boys, higher cortisol concentrations were associated with higher insulin, glucose, and HOMA-IR; in girls, with higher leptin, insulin, and HOMA-IR, but not with higher glucose.

The research contributes to the narrative of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi regarding the possible link between metabolic stress and reduced insulin sensitivity. However, it did not measure the insulin receptor or the IRS-1 and IRS-2 proteins. Independent studies indicate that excess glucocorticoids can alter insulin signaling in muscle, but such effects are tissue- and experimental model-dependent. Confirmation of the book's specific narrative is therefore primarily mechanistic and indirect.

Analyzed study

Mechanisms of stress, energy homeostasis and insulin resistance in European adolescents--the HELENA study

Huybrechts I, De Vriendt T, Breidenassel C, Rogiers J, Vanaelst B, Cuenca-García M, Moreno LA, González-Gross M, Roccaldo R, Kafatos A, Clays E, Bueno G, Beghin L, Sjöstrom M, Manios Y, Molnár D, Pisa PT, De Henauw S, HELENA Study Group

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014

DOI: 10.1016/j.numecd.2014.04.014

PMID: 24907850

The research question was whether the activity of the stress system, represented by fasting blood cortisol concentration, was associated with signs of impaired energy control and lower insulin sensitivity in European adolescents. The authors' hypothesis was that higher cortisol levels could be accompanied by higher values of insulin, glucose, leptin, and HOMA-IR.

The reason for the citation in paragraphs 4.1 and 4.2 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is the general link between metabolic stress, altered energy balance, and reduced insulin sensitivity. The study documents this link at an observational level: it detects associations between biomarkers measured at the same time, but it does not prove that cortisol causes insulin resistance.

A clarification is important: the publication did not measure insulin receptor expression in peripheral tissues, its activity, the cellular distribution of IRS-1 and IRS-2 proteins, nor markers of chronic inflammation. Consequently, its contribution to the book's text concerns the more general segment of the chain, i.e., metabolic stress associated with lower insulin sensitivity, not the direct demonstration of molecular modifications of the receptor or IRS proteins.

Materials and methods of the original study

The study used data from the HELENA-CSS project with a cross-sectional observational design: exposures and outcomes were measured during the same period, without follow-up. A total of 723 adolescents aged between 12.5 and 17.5 years from ten European cities were included. This information does not allow for the determination of which variable appeared first.

Fasting blood samples were collected to measure cortisol, leptin, insulin, and glucose. Leptin is a hormone produced primarily by adipose tissue that signals the body's available energy reserves. The HOMA-IR, or the homeostatic model assessment for insulin resistance, was calculated using fasting insulin and glucose concentrations; it is an indirect estimate rather than a direct measure of insulin action in tissues.

The authors also evaluated age, body fat percentage, and duration of exclusive breastfeeding. Analyses were conducted separately for boys and girls. Pearson correlations and hierarchical linear models were calculated, considering the city as a clustering unit and adjusting the results for age, body fat, and duration of exclusive breastfeeding. Detailed inclusion and exclusion criteria, the data collection period, absolute biomarker values, and laboratory analytical procedures are not reported in the available material, which consists only of the abstract.

Results

In boys, higher cortisol was associated with higher insulin, higher glucose (r = 0.315; p < 0.001), and higher HOMA-IR. The r coefficient indicates the direction and strength of a linear relationship: all these values were positive, meaning that as cortisol levels increased, the indicators considered also increased on average. The strength of the association was small for insulin and HOMA-IR and more pronounced, though not high, for glucose.

In girls, higher cortisol was associated with higher leptin, higher insulin, and higher HOMA-IR. No statistically significant association was observed between cortisol and glucose. In simple terms, in girls with higher cortisol, glucose was not systematically higher in the analyzed sample.

According to the abstract, the observed associations remained independent of age, body fat percentage, and duration of exclusive breastfeeding after applying hierarchical models. However, the corrected coefficients of the models, the relative confidence intervals, and the P-values of the adjusted analyses are not reported in the available material.

The result most relevant to the book's narrative is that higher cortisol was associated with higher HOMA-IR in both sexes. This is compatible with lower insulin sensitivity, but HOMA-IR does not identify the specific point in the insulin pathway that might be involved: it therefore does not allow the phenomenon to be attributed to the insulin receptor, IRS-1, IRS-2, or a single tissue.

Interpretation

In plain language, the data indicate that adolescents with higher cortisol levels showed, on average, blood markers consistent with a greater difficulty for the body to maintain an efficient insulin response. This does not mean that every boy or girl with higher cortisol will develop a metabolic disease, nor that cortisol is the sole cause of the alteration.

The potential biological significance is consistent with the role of glucocorticoids, a family of hormones that includes cortisol and coordinates the stress response and energy availability. When the glucocorticoid signal is excessive or persistent, it can promote a reduced tissue response to insulin. The study analyzed, however, only observed blood concentrations and metabolic estimates; it did not evaluate the phosphorylation of the insulin receptor—that is, the initial chemical activation of the receptor—nor the quantity or localization of IRS.

Regarding the book's sections, the publication therefore supports an indirect link: conditions associated with metabolic stress can be accompanied by lower insulin sensitivity. The subsequent part of the narrative, which suggests that insulin receptor activity and IRS proteins in peripheral tissues may be involved, requires specific experimental evidence. Studies on rodents, muscle cells, and adipose cells show that the effect of glucocorticoids can indeed involve these nodes of the insulin pathway, but also that the direction of the effect changes based on the cell type and the experimental condition.

Independent confirming evidence

Observational confirmation in the young population comes from a study conducted on 205 overweight Latin American children and adolescents, aged between 8 and 13, who were at risk for type 2 diabetes. Higher morning cortisol was associated with lower insulin sensitivity as measured by dynamic metabolic tests, both in the cross-sectional analysis and during the observation period. This result confirms the narrative segment regarding higher cortisol and lower insulin response, using a more direct measure of insulin action than HOMA-IR. However, the sample was selected based on being overweight and ethnic origin, and therefore does not represent all adolescents [1].

The molecular step involving the receptor and IRS-1 is supported by an experiment in male rats treated for five days with cortisone and compared with pair-fed controls. In skeletal muscle, cortisone increased the amount of insulin receptor by 36%, but reduced its tyrosine phosphorylation to 69% of the control and reduced the IRS-1 content by 50%. In other words, having more receptors did not mean a more efficient signal: a smaller proportion of receptors was activated by insulin. The study experimentally confirms that glucocorticoids can reduce the efficiency of the receptor-IRS signal in muscle, but it does not prove that the same occurs in healthy adolescents [2].

A subsequent study strengthened the link between glucocorticoids and IRS-1 in muscle. In human and rodent muscle cell cultures, dexamethasone reduced insulin-stimulated glucose uptake, reduced IRS-1 messenger RNA and protein, and increased the inactivating phosphorylation of IRS-1 at serine 307. In mouse models, inhibition of the 11β-HSD1 enzyme, which locally increases the availability of active glucocorticoids, improved insulin sensitivity and reduced this inactivating signal. This evidence supports the possible pathway of hormonal stress → alteration of IRS-1 → lower insulin signaling, but it remains predominantly cellular and animal-based [3].

The three publications are independent of the HELENA study and form a coherent chain: in young humans, higher cortisol can be associated with lower insulin sensitivity; in experimental models, excess glucocorticoids can reduce the efficiency of the insulin receptor and IRS-1. None of these findings, however, proves that the associations observed in the HELENA sample depended specifically on a change in the receptor or the cellular distribution of IRS.

Conflicting evidence

Directly relevant evidence shows that the effect of glucocorticoids is not uniform. In primary human preadipocytes, which are precursor cells to fat cells, pretreatment with glucocorticoids increased the expression of the insulin receptor, IRS-1, and IRS-2, and increased the activation of AKT, a protein that transmits the insulin signal within the cell. In this specific model, therefore, glucocorticoids increased rather than reduced insulin sensitivity, preparing the cells for adipose differentiation [4].

This conflicting result does not invalidate the observations regarding muscle or metabolic markers in adolescents. However, it indicates that it is incorrect to describe glucocorticoids as invariable inhibitors of the insulin receptor or IRS. Cell type, duration of exposure, hormone concentration, the cell's differentiation state, and the metabolic context can all modify the response. No further directly conflicting evidence of sufficient relevance has been identified in the general adolescent population; this does not prove the absence of contrary findings.

Summary table of evidence

The table distinguishes the observational study under review from independent research that confirms or defines the individual steps of the narrative.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Cross-sectional observational 723 European adolescents, 12.5-17.5 years Higher cortisol associated with higher HOMA-IR; differences between boys and girls biologically consistent evidence moderate
[1] Longitudinal and cross-sectional observational 205 overweight Latin American children and adolescents, 8-13 years Higher morning cortisol associated with lower insulin sensitivity direct confirmation moderate
[2] Experimental animal Male Sprague-Dawley rats, skeletal muscle Cortisone reduces insulin receptor phosphorylation and IRS-1 content indirect confirmation moderate
[3] Cellular and animal Human and rodent myotubes, muscle and murine models Glucocorticoids reduce IRS-1 and insulin-stimulated glucose utilization indirect confirmation moderate
[4] Cellular Primary human preadipocytes Glucocorticoids increase insulin receptor, IRS-1, and insulin sensitivity in the model discordant evidence preliminary

Confirmation of the evidence

Claim in the book

In sections 4.1 and 4.2 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, it is stated that conditions of altered energy balance, chronic inflammation, and metabolic stress can contribute to reduced expression or activity of the insulin receptor in peripheral tissues and reduced insulin sensitivity, including through alterations of IRS.

Metabolic stress/higher cortisol → lower insulin sensitivity → possible alterations in insulin receptor-IRS signaling in peripheral tissues

The publication subject to the Evidence Review was used in the book to support the following passage: in adolescents, markers of the stress system and altered energy balance can be associated with lower insulin sensitivity. The study does not directly document reduced insulin receptor expression or alterations in the cellular distribution of IRS-1 or IRS-2.

The correspondence between the original study and the text "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi exists, but it concerns the metabolic-observational level of the narrative. In the HELENA sample, higher cortisol was associated with higher HOMA-IR in both sexes; this is consistent with lower insulin sensitivity. Another study in overweight young people found that higher morning cortisol was associated with lower insulin sensitivity, providing independent confirmation in young humans [1].

The molecular part of the chain requires different sources. In rat muscle treated with cortisone, insulin receptor activation and the amount of IRS-1 decreased [2]. In cellular and murine muscle models, glucocorticoids reduced IRS-1 and insulin-stimulated glucose uptake [3]. These results make the transition from hormonal stress to less efficient insulin signaling biologically plausible, but they do not authorize the automatic transfer of the mechanism to the peripheral tissues of HELENA adolescents. Furthermore, in human preadipocytes, the effect was the opposite, with an increase in insulin receptor, IRS-1, and insulin sensitivity [4].

Overall level of confirmation

INDIRECT CONFIRMATION

The original study directly supports only the association between higher cortisol and indicators consistent with increased insulin resistance. Independent research links this picture to modifications of the insulin receptor and IRS-1, primarily in muscle, cells, and animal models, while one cellular study shows an opposite effect in developing adipose tissue.

Conclusions

The HELENA study shows that, in European adolescents, higher cortisol concentrations were associated with indicators of lower insulin sensitivity, with differences between boys and girls. This result is consistent with the general section of the book regarding metabolic stress and the insulin response.

However, the publication does not demonstrate that the insulin receptor is less expressed or less active, nor that IRS proteins are redistributed in the cells of adolescents. Independent evidence makes a link between glucocorticoids and alterations in receptor-IRS signaling plausible, especially in muscle, but this link is tissue-dependent and requires direct validation in young humans. The narrative is therefore supported at an observational and mechanistic level, without a complete causal demonstration.

Overall assessment

The relationship between higher cortisol and lower insulin sensitivity in adolescents is fairly well supported by convergent observational evidence. The link with the insulin receptor and IRS-1 is confirmed primarily at a mechanistic level in muscle, cells, and animal models. Consistency with the book is present, but the specific extension to adolescent peripheral tissues remains indirect.

References

[1] Cortisol Is Negatively Associated with Insulin Sensitivity in Overweight Latino Youth

Adam TC, Hasson RE, Ventura EE, Toledo-Corral C, Le KA, Mahurkar S, et al., 2010

The Journal of Clinical Endocrinology & Metabolism

[2] Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ, 1993

Journal of Clinical Investigation

[3] 11b-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle

Morgan SA, Sherlock M, Gathercole LL, Lavery GG, Lenaghan C, Bujalska IJ, et al., 2009

Diabetes

[4] Insulin Sensitization of Human Preadipocytes through Glucocorticoid Hormone Induction of Forkhead Transcription Factors

Tomlinson JJ, Boudreau A, Wu D, Salem HA, Carrigan A, Gagnon A, et al., 2010

Molecular Endocrinology

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.